Literature DB >> 14739494

Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.

Andreas Weinhäusel1, Annemarie Behmel, Bruce A J Ponder, Oskar A Haas, Bruno Niederle, Alois Gessl, Heinrich Vierhapper, Roswitha Pfragner.   

Abstract

A unilateral, apparently sporadic pheochromocytoma was removed from the right adrenal of a 73-yr-old Caucasian woman. At the time of surgery, germline DNA from the patient was not available. However, a continuous cell line (KNA) established from the tumor showed a heterozygous sequence variant TGC (cysteine) to TGG (tryptophan) in exon 10, codon 611 of the RET proto-oncogene. Subsequent genetic testing of the patient and her offspring revealed the same base-change in herself, one daughter, one son, and the only grandson, confirming hereditary disease classified as MEN2A-2. Clinical follow up of the patient revealed elevated serum calcitonin after 6 yr. Thyroidectomy was performed and revealed a small medullary thyroid carcinoma. The patient's children thus far show no evidence of MEN2, but C-cell hyperplasia has been diagnosed in the grandson. Our serendipitous finding of a MEN2A-2 mutation in a patient with initial diagnosis of late onset, unilateral, "sporadic" pheochromocytoma would argue for routine mutation screening of even elderly patients presenting with a pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14739494     DOI: 10.1385/ep:14:4:375

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  36 in total

Review 1.  The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.

Authors:  B A Ponder
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

Review 2.  Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.

Authors:  C Eng
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

3.  Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

Authors:  D P Smith; C Houghton; B A Ponder
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

4.  Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.

Authors:  F J Pomares; R Cañas; J M Rodriguez; A M Hernandez; P Parrilla; F J Tebar
Journal:  Clin Endocrinol (Oxf)       Date:  1998-02       Impact factor: 3.478

5.  Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

Authors:  R M Hofstra; T Stelwagen; R P Stulp; D de Jong; M Hulsbeek; E J Kamsteeg; A van den Berg; R M Landsvater; A Vermey; W M Molenaar; C J Lips; C H Buys
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

6.  A patient with MEN 2 and multiple mutations of RET in the germline.

Authors:  C A Koch; S C Huang; A O Vortmeyer; Z Zhuang; G P Chrousos; K Pacak
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

7.  Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.

Authors:  L Nguyen; P Niccoli-Sire; P Caron; D Bastie; B Maes; G Chabrier; O Chabre; V Rohmer; P Lecomte; J F Henry; B Conte-Devolx
Journal:  Eur J Endocrinol       Date:  2001-01       Impact factor: 6.664

8.  Expression of the ret proto-oncogene in phaeochromocytoma. An in situ hybridization and northern blot study.

Authors:  X Matias-Guiu; A Colomer; E Mato; M Cuatrecasas; P Komminoth; J Prat; H Wolfe
Journal:  J Pathol       Date:  1995-05       Impact factor: 7.996

9.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

10.  Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases.

Authors:  S Casanova; M Rosenberg-Bourgin; D Farkas; C Calmettes; N Feingold; H M Heshmati; R Cohen; B Conte-Devolx; P J Guillausseau; C Houdent
Journal:  Clin Endocrinol (Oxf)       Date:  1993-05       Impact factor: 3.478

View more
  1 in total

1.  Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

Authors:  Thereasa A Rich; Lei Feng; Naifa Busaidy; Gilbert J Cote; Robert F Gagel; Mimi Hu; Camilo Jimenez; Jeffrey E Lee; Nancy Perrier; Steven I Sherman; Steven G Waguespack; Anita Ying; Elizabeth Grubbs
Journal:  Thyroid       Date:  2014-06-06       Impact factor: 6.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.